The approval of novel orphan drug designations continues to grow, while many existing rare disease therapies are receiving approval for expanded indications.…


FDA smacks third Alkem plant with Form 483

As U.S. rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters

India wants to sell low-cost drugs in Trump’s America, but quality questions persist